Philips Reaffirms 2026 Outlook After Strong Q1 Sales and Margin Beat 
Samsung Surpasses $1 Trillion Market Cap Amid AI Chip Boom and Apple Partnership Talks 
Regis Resources and Vault Minerals to Merge in $10.7B Gold Deal 
Meta Plans $13B AI Data Center Financing in Texas Amid Surging Big Tech Investment 
Volvo Car Sales Drop 10% in Early 2026 Despite Growth in Electric Vehicles 
Lufthansa Q1 Loss Narrows as Strong Summer Travel Demand Boosts Outlook 
Anthropic’s $1.5B AI Venture with Wall Street Firms Targets Private Equity Market 
Strategy Hints at Bitcoin Sales to Cover Dividends After Massive Q1 Loss 
Pinterest Stock Surges After Strong Q1 2026 Earnings Beat Expectations 
BMW Keeps 2026 Outlook Despite 25% Profit Drop Amid Tariff Pressure 
BHP Attracts AI-Focused Investors as Copper Demand Surges 
Strategy Reports Q1 Loss as Bitcoin Holdings Trigger $14.46 Billion Unrealized Hit 
AMD Q1 Earnings Surge on AI Demand, Stock Jumps After Strong Guidance 
Infineon Raises 2026 Outlook as AI Data Center Chip Demand Surges 
Berkshire Hathaway Meeting Sees Shift as Greg Abel Steps Into Leadership Spotlight 
GameStop Proposes $56 Billion eBay Acquisition in Bold Strategic Move 
NEW YORK, May 07, 2018 -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug instruments that provide painless and precise injections, today announced that it will be presenting at the 3rd annual Disruptive Growth & Healthcare Conference in New York City on Tuesday, May 8th at 3:50 PM, Eastern Time. Interim Chief Executive Officer of Milestone Scientific, Leonard Osser, will be presenting, as well as meeting with investors. Mr. Osser will also be presenting on the Disruptive Injectables & Oncology Panel at 1:45 PM on May 8th.
The 2018 Disruptive Growth & Healthcare Conference will offer investors the opportunity to discover life science companies focusing on solutions for unmet medical needs and growth companies with disruptive technologies and business models.
About Milestone Scientific Inc.
Milestone Scientific Inc. (MLSS) is a biomedical technology research and development company that patents, designs and develops innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. Milestone's computer-controlled systems are designed to make injections precise, efficient, and virtually painless. Milestone’s proprietary DPS Dynamic Pressure Sensing technology® is our technology platform that advances the development of next-generation instruments, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional anesthesia procedures and intra-articular joint injections. For more information please visit our website: www.milestonescientific.com.
About RHK Capital:
Advisory Group Equity Services, Ltd. (dba RHK Capital) was founded in 1984. RHK Capital is a boutique investment banking firm specializing in small to medium-sized transactions. RHK is led by a management team with extensive financial industry experience and a desire to provide companies and individuals with the tools and expertise to accomplish their financial goals. In addition to investment banking, RHK has grown to include businesses in general securities, emerging market securities, distressed and high yield debt securities, investment management, mortgages, and business lending. As a division of Advisory Group Equity Services (AGES), all securities are offered through Advisory Group Equity Services Ltd., a registered broker-dealer, member of the Financial Industry Regulatory Authority and the Securities Investor Protection Corporation.
Contact:
David Waldman or Natalya Rudman
Crescendo Communications, LLC
Email: [email protected]
Tele: 212-671-1020
